Long-Acting β-Agonists With vs Without Inhaled Corticosteroids for COPD Reply

被引：1

作者：

Gershon, Andrea S. ^{[1
,2
]}

Campitelli, Michael A. ^{[2
]}

Stanbrook, Matthew B. ^{[3
]}

机构：

[1] Univ Toronto, Dept Med, Toronto, ON, Canada

[2] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada

[3] Univ Toronto, Div Respirol, Toronto, ON, Canada

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 03期

关键词：

RISK;

D O I：

10.1001/jama.2014.16479

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：305 / 306

页数：2

共 50 条

[1] Safety and Efficacy of Combined Long-Acting β-Agonists and Inhaled Corticosteroids vs Long-Acting α-Agonists Monotherapy for Stable COPD A Systematic Review
Rodrigo, Gustavo J.
Castro-Rodriguez, Jose A.
Plaza, Vicente
CHEST, 2009, 136 (04) : 1029 - 1038
[2] Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD
Fuso, L.
Mores, N.
Valente, S.
Malerba, M.
Montuschi, P.
CURRENT MEDICINAL CHEMISTRY, 2013, 20 (12) : 1477 - 1495
[3] Use of long-acting β-agonists and inhaled corticosteroids
Glassroth, Jeffrey
ANNALS OF INTERNAL MEDICINE, 2006, 145 (09) : 710 - 710
[4] Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists
Mapel, DW
Hurley, JS
Roblin, D
Roberts, M
Davis, KJ
Schreiner, R
Frost, FJ
RESPIRATORY MEDICINE, 2006, 100 (04) : 595 - 609
[5] Safety of Long-Acting beta Agonists (LABA) with or without Inhaled Corticosteroids in Asthma
Sadatsafavi, Mohsen
Marra, Carlo
Lynd, Larry
FitzGerald, Mark
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 19 - 19
[6] Long-Acting β2 Agonists and Inhaled Corticosteroids in Asthma
Lipworth, Brian J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (09) : 853 - 854
[7] Inhaled combination therapy with long-acting β2-agonists and corticosteroids in stable COPD
Cazzola, M
Dahl, R
CHEST, 2004, 126 (01) : 220 - 237
[8] EFFICACY AND SAFETY OF LONG-ACTING BETA AGONISTS plus LONG ACTING MUSCARINIC ANTAGONISTS VS. LONG-ACTING BETA AGONISTS plus INHALED CORTICOSTEROIDS IN COPD: A META-ANALYSIS
Villalobos, R. E.
David-Wang, A.
Magallanes, J.
RESPIROLOGY, 2016, 21 : 177 - 177
[9] Efficacy and safety of Long-acting Beta-agonists plus Long-acting muscarinic antagonists vs Long-acting Beta-agonists plus Inhaled corticosteroids in COPD: a meta-analysis
Villalobos, Ralph Elvi
David-Wang, Aileen
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[10] EFFICACY AND SAFETY OF LONG-ACTING BETA AGONISTS plus LONG ACTING MUSCARINIC ANTAGONISTS VS. LONG-ACTING BETA AGONISTS plus INHALED CORTICOSTEROIDS IN COPD: A META-ANALYSIS
Villalobos, R. E.
David-Wang, A.
Magallanes, J.
THORAX, 2016, 71 : A113 - A114

← 1 2 3 4 5 →